Cancer cell metabolism and the modulating effects of nitric oxide

Free Radical Biology and Medicine

Volumn 79, Issue , 2015, Pages 324-336

  Chang, Ching Fang ^a   Diers, Anne R ^a   Hogg, Neil ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; PYRUVATE KINASE;

BIOENERGY; BIOGENESIS; BREAST CANCER; CANCER CELL; CARBOXYLATION; CELL METABOLISM; CITRIC ACID CYCLE; GLYCOLYSIS; HUMAN; MITOCHONDRIAL RESPIRATION; MODULATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENERGY METABOLISM; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ENERGY METABOLISM; HUMANS; NEOPLASMS; NITRIC OXIDE;

EID: 84923220635     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.11.012     Document Type: Review

References (234)

1. J.H. Martin, S. Begum, O. Alalami, A. Harrison, and K.W. Scott Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer Tumour Biol. 21 2000 90 97
2. M. Vakkala, P. Paakko, and Y. Soini eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinoma Int. J. Oncol. 17 2000 667 671
3. C. DeSantis, J. Ma, L. Bryan, and A. Jemal Breast cancer statistics, 2013 CA Cancer J. Clin 64 2014 52 62
4. J.R. Cantor, and D.M. Sabatini Cancer cell metabolism: one hallmark, many faces Cancer Discov 2 2012 881 898
5. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
6. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
7. A. Isidoro, M. Martinez, P.L. Fernaíndez, A.D. Ortega, G. Santamaria, M. Chamorro, J.C. Reed, and J.M. Cuezva Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer Biochem. J. 378 2004 17 20
8. J.F. Barger, and D.R. Plas Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis Endocr. Relat. Cancer 17 2010 R287 R304
9. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even warburg did not anticipate Cancer Cell 21 2012 297 308
10. T. Contractor, and C.R. Harris p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2 Cancer Res. 72 2012 560 567
11. C.V. Dang MYC, Metabolism, Cell Growth, and Tumorigenesis Cold Spring Harbor Perspect. Med 3 2013
12. R.C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L.A. Lee, and C.V. Dang Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc J. Biol. Chem. 275 2000 21797 21800
13. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
14. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
15. O. Warburg, F. Wind, and E. Negerlein The metabolism of tumors in the body J. Gen. Physiol. 8 6 1927 519 530
16. W.H. Koppenol, P.L. Bounds, and C.V. Dang Otto Warburg's contributions to current concepts of cancer metabolism Nat. Rev. Cancer 11 2011 325 337
17. S. Weinhouse, O. Warburg, D. Burk, and A.L. Schade On respiratory impairment in cancer cells Science 124 1956 267 272
18. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418
19. T. Wang, C. Marquardt, and J. Foker Aerobic glycolysis during lymphocyte proliferation Nature 261 1976 702 705
20. C.J. Hedeskov Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes Biochem. J. 110 1968 373 380
21. K. Brand Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism Biochem. J. 228 1985 353 361
22. R.J. DeBerardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, S. Wehrli, and C.B. Thompson Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc. Natl. Acad. Sci. USA 104 2007 19345 19350
23. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat. Rev. Cancer 11 2011 85 95
24. S. Dhup, R.K. Dadhich, P.E. Porporato, and P. Sonveaux Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis Curr. Pharm. Des 18 2012 1319 1330
25. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat. Rev. Cancer 2 2002 683 693
26. M.L. Macheda, S. Rogers, and J.D. Best Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer J. Cell. Physiol. 202 2005 654 662
27. K.M. Kennedy, and M.W. Dewhirst Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation Future Oncol 6 2009 127 148
28. R.A. Medina, and G.I. Owen Glucose transporters: expression, regulation and cancer Biol. Res. 35 2002 9 26
29. M.K. Schwartz Enzymes as prognostic markers and therapeutic indicators in patients with cancer Clin. Chim. Acta 206 1992 77 82
30. M. Grover-McKay, S.A. Walsh, E.A. Seftor, P.A. Thomas, and M.J. Hendrix Role for glucose transporter 1 protein in human breast cancer Pathol. Oncol. Res. 4 1998 115 120
31. J.E. Wilson Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function J. Exp. Biol. 206 2003 2049 2057
32. S.P. Mathupala, Y.H. Ko, P.L. Pedersen, and I.I. Hexokinase Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786
33. R.A. Nakashima, P.S. Mangan, M. Colombini, and P.L. Pedersen Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N′-dicyclohexlycarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC Biochemistry 25 1986 1015 1021
34. E. Bustamante, and P.L. Pedersen High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase Proc. Natl. Acad. Sci. USA 74 1977 3735 3739
35. K.K. Arora, and P.L. Pedersen Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP J. Biol. Chem. 263 1988 17422 17428
36. I.A. Rose, and J.V.B. Warms Stability of hexokinase II in Vitro and in ascites tumor cells Arch. Biochem. Biophys. 213 1982 625 634
37. J.G. Pastorino, N. Shulga, and J.B. Hoek Mitochondrial binding of hexokinase II inhibits bax-induced cytochrome c release and apoptosis J. Biol. Chem. 277 2002 7610 7618
38. S. Vora, J.P. Halper, and D.M. Knowles Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy Cancer Res. 45 1985 2993 3001
39. G. Wang, Z. Xu, C. Wang, F. Yao, J. Li, C. Chen, and S. Sun Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues Oncol. Lett 6 2013 1701 1706
40. E. Van Schaftingen, M.F. Jett, L. Hue, and H.G. Hers Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors Proc. Natl. Acad. Sci. USA 78 1981 3483 3486
41. D.A. Okar, A.J. Lange, A. Manzano, A. Navarro-Sabate, L. Riera, and R. Bartrons PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate Trends Biochem. Sci. 26 2001 30 35
42. T. Atsumi, J. Chesney, C. Metz, L. Leng, S. Donnelly, Z. Makita, R. Mitchell, and R. Bucala High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers Cancer Res. 62 2002 5881 5887
43. M.N. Calvo, R. Bartrons, E. Castano, J.C. Perales, A. Navarro-Sabate, and A. Manzano PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells FEBS Lett. 580 2006 3308 3314
44. B. Clem, S. Telang, A. Clem, A. Yalcin, J. Meier, A. Simmons, M.A. Rasku, S. Arumugam, W.L. Dean, J. Eaton, A. Lane, J.O. Trent, and J. Chesney Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth Mol. Cancer Ther. 7 2008 110 120
45. B.F. Clem, J. O'Neal, G. Tapolsky, A.L. Clem, Y. Imbert-Fernandez, D.A. Kerr, A.C. Klarer, R. Redman, D.M. Miller, J.O. Trent, S. Telang, and J. Chesney Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer Mol. Cancer Ther. 12 2013 1461 1470
46. S. Mazurek, C.B. Boschek, F. Hugo, and E. Eigenbrodt Pyruvate kinase type M2 and its role in tumor growth and spreading Semin. Cancer Biol. 15 2005 300 308
47. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233
48. M. Cortes-Cros, C. Hemmerlin, S. Ferretti, J. Zhang, J.S. Gounarides, H. Yin, A. Muller, A. Haberkorn, P. Chene, W.R. Sellers, and F. Hofmann M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth Proc. Natl. Acad. Sci. USA 110 2013 489 494
49. W.J. Israelsen, T.L. Dayton, S.M. Davidson, B.P. Fiske, A.M. Hosios, G. Bellinger, J. Li, Y. Yu, M. Sasaki, J.W. Horner, L.N. Burga, J. Xie, M.J. Jurczak, R.A. DePinho, C.B. Clish, T. Jacks, R.G. Kibbey, G.M. Wulf, D. Di Vizio, G.B. Mills, L.C. Cantley, and M.G. Vander Heiden PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells Cell 155 2013 397 409
50. D. Anastasiou, G. Poulogiannis, J.M. Asara, M.B. Boxer, J.k. Jiang, M. Shen, G. Bellinger, A.T. Sasaki, J.W. Locasale, D.S. Auld, C.J. Thomas, M.G. Vander Heiden, and L.C. Cantley Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses Science 334 2011 1278 1283
51. E.I. Chen, J. Hewel, J.S. Krueger, C. Tiraby, M.R. Weber, A. Kralli, K. Becker, J.R. Yates, and B. Felding-Habermann Adaptation of energy metabolism in breast cancer brain metastases Cancer Res. 67 2007 1472 1486
52. Z.T. Schafer, A.R. Grassian, L. Song, Z. Jiang, Z. Gerhart-Hines, H.Y. Irie, S. Gao, P. Puigserver, and J.S. Brugge Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment Nature 461 2009 109 113
53. J. Boada, T. Roig, X. Perez, A. Gamez, R. Bartrons, M. Cascante, and J. Bermudez Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress FEBS Lett. 480 2000 261 264
54. L.Z. Milgraum, L.A. Witters, G.R. Pasternack, and F.P. Kuhajda Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin. Cancer Res. 3 1997 2115 2120
55. D.E. Bauer, G. Hatzivassiliou, F. Zhao, C. Andreadis, and C.B. Thompson ATP citrate lyase is an important component of cell growth and transformation Oncogene 24 2005 6314 6322
56. W.W. Souba Glutamine and cancer Ann. Surg. 218 1993 715 728
57. M.A. Medina Glutamine and cancer J. Nutr. 131 2001 2539S 2542S
58. E.R. Mardis, L. Ding, D.J. Dooling, D.E. Larson, M.D. McLellan, K. Chen, D.C. Koboldt, R.S. Fulton, K.D. Delehaunty, S.D. McGrath, L.A. Fulton, D.P. Locke, V.J. Magrini, R.M. Abbott, T.L. Vickery, J.S. Reed, J.S. Robinson, T. Wylie, S.M. Smith, L. Carmichael, J.M. Eldred, C.C. Harris, J. Walker, J.B. Peck, F. Du, A.F. Dukes, G.E. Sanderson, A.M. Brummett, E. Clark, J.F. McMichael, R.J. Meyer, J.K. Schindler, C.S. Pohl, J.W. Wallis, X. Shi, L. Lin, H. Schmidt, Y. Tang, C. Haipek, M.E. Wiechert, J.V. Ivy, J. Kalicki, G. Elliott, R.E. Ries, J.E. Payton, P. Westervelt, M.H. Tomasson, M.A. Watson, J. Baty, S. Heath, W.D. Shannon, R. Nagarajan, D.C. Link, M.J. Walter, T.A. Graubert, J.F. DiPersio, R.K. Wilson, and T.J. Ley Recurring mutations found by sequencing an acute myeloid leukemia genome N. Engl. J. Med. 361 2009 1058 1066
59. H. Yan, D.W. Parsons, G. Jin, R. McLendon, B.A. Rasheed, W. Yuan, I. Kos, I. Batinic-Haberle, S. Jones, G.J. Riggins, H. Friedman, A. Friedman, D. Reardon, J. Herndon, K.W. Kinzler, V.E. Velculescu, B. Vogelstein, and D.D. Bigner IDH1 and IDH2 Mutations in Gliomas N. Engl. J. Med. 360 2009 765 773
60. L. Dang, D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, E.M. Driggers, V.R. Fantin, H.G. Jang, S. Jin, M.C. Keenan, K.M. Marks, R.M. Prins, P.S. Ward, K.E. Yen, L.M. Liau, J.D. Rabinowitz, L.C. Cantley, C.B. Thompson, M.G. Vander Heiden, and S.M. Su Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 2009 739 744
61. M. Tahiliani, K.P. Koh, Y. Shen, W.A. Pastor, H. Bandukwala, Y. Brudno, S. Agarwal, L.M. Iyer, D.R. Liu, L. Aravind, and A. Rao Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 Science 324 2009 930 935
62. W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang, S.H. Kim, S. Ito, C. Yang, P. Wang, M.T. Xiao, L.x. Liu, W.q. Jiang, J. Liu, J.y. Zhang, B. Wang, S. Frye, Y. Zhang, Y.h. Xu, Q.y. Lei, K.L. Guan, S.m. Zhao, and Y. Xiong Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30
63. M.E. Figueroa, O. bdel-Wahab, C. Lu, P.S. Ward, J. Patel, A. Shih, Y. Li, N. Bhagwat, A. Vasanthakumar, H.F. Fernandez, M.S. Tallman, Z. Sun, K. Wolniak, J.K. Peeters, W. Liu, S.E. Choe, V.R. Fantin, E. Paietta, B. Lowenberg, J.D. Licht, L.A. Godley, R. Delwel, P.J.M. Valk, C.B. Thompson, R.L. Levine, and A. Melnick Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
64. J.R. Prensner, and A.M. Chinnaiyan Metabolism unhinged: IDH mutations in cancer Nat. Med 17 2011 291 293
65. A.R. Mullen, W.W. Wheaton, E.S. Jin, P.H. Chen, L.B. Sullivan, T. Cheng, Y. Yang, W.M. Linehan, N.S. Chandel, and R.J. DeBerardinis Reductive carboxylation supports growth in tumour cells with defective mitochondria Nature 481 2012 385 388
66. D.R. Wise, P.S. Ward, J.E. Shay, J.R. Cross, J.J. Gruber, U.M. Sachdeva, J.M. Platt, R.G. DeMatteo, M.C. Simon, and C.B. Thompson Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability Proc. Natl. Acad. Sci. USA 108 2011 19611 19616
67. A.R. Mullen, Z. Hu, X. Shi, L. Jiang, L.K. Boroughs, Z. Kovacs, R. Boriack, D. Rakheja, L.B. Sullivan, W.M. Linehan, N.S. Chandel, and R.J. DeBerardinis Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects Cell Rep 7 2014 1679 1690
68. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 4 2003 257 262
69. R.J. Shaw, and L.C. Cantley Ras, PI(3)K and mTOR signalling controls tumour cell growth Nature 441 2006 424 430
70. T.L. Yuan, and L.C. Cantley PI3K pathway alterations in cancer: variations on a theme Oncogene 27 2008 5497 5510
71. R.L. Elstrom, D.E. Bauer, M. Buzzai, R. Karnauskas, M.H. Harris, D.R. Plas, H. Zhuang, R.M. Cinalli, A. Alavi, C.M. Rudin, and C.B. Thompson Akt stimulates aerobic glycolysis in cancer cells Cancer Res. 64 2004 3892 3899
72. J. Deprez, D. Vertommen, D.R. Alessi, L. Hue, and M.H. Rider Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades J. Biol. Chem. 272 1997 17269 17275
73. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R.B. Robey, and N. Hay Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev. 15 2001 1406 1418
74. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol. Cell. Biol. 21 2001 3995 4004
75. F.P. Kuhajda Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 16 2000 202 208
76. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
77. S. Yoon, M.Y. Lee, S.W. Park, J.S. Moon, Y.K. Koh, Y.H. Ahn, B.W. Park, and K.S. Kim Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells J. Biol. Chem. 282 2007 26122 26131
78. T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Role of the phosphatidylinositol 3-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells Cancer Res. 62 2002 642 646
79. Y.A. Yang, W.F. Han, P.J. Morin, F.J. Chrest, and E.S. Pizer Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase Exp. Cell Res. 279 2002 80 90
80. R. Lupu, and J.A. Menendez Targeting fatty acid synthase in breast and endometrial cancer: an alternative to selective estrogen receptor modulators? Endocrinology 147 2006 4056 4066
81. D.C. Berwick, I. Hers, K.J. Heesom, S.K. Moule, and J.M. Tavar+¬ The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes J. Biol. Chem. 277 2002 33895 33900
82. H. Zhong, A.M. De Marzo, E. Laughner, M. Lim, D.A. Hilton, D. Zagzag, P. Buechler, W.B. Isaacs, G.L. Semenza, and J.W. Simons Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases Cancer Res. 59 1999 5830 5835
83. G.L. Semenza HIF-1: upstream and downstream of cancer metabolism Curr. Opin. Genet. Dev 20 2010 51 56
84. R.K. Bruick, and S.L. McKnight A Conserved family of prolyl-4-hydroxylases that modify HIF Science 294 2001 1337 1340
85. J. Kaelin, and P.J. Ratcliffe Oxygen sensing by metazoans: the central role of the hif hydroxylase pathway Mol. Cell 30 2008 393 402
86. G.L. Semenza, P.H. Roth, H.M. Fang, and G.L. Wang Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 J. Biol. Chem. 269 1994 23757 23763
87. X. Xia, M.E. Lemieux, W. Li, J.S. Carroll, M. Brown, X.S. Liu, and A.L. Kung Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis Proc. Natl. Acad. Sci. USA 106 2009 4260 4265
88. D.R. Mole, C. Blancher, R.R. Copley, P.J. Pollard, J.M. Gleadle, J. Ragoussis, and P.J. Ratcliffe Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts J. Biol. Chem. 284 2009 16767 16775
89. I.F. Robey, A.D. Lien, S.J. Welsh, B. Baggett, and R.J. Gillies Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors Neoplasia 7 2005 324 330
90. M.S. Ullah, A.J. Davies, and A.P. Halestrap The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism J. Biol. Chem. 281 2006 9030 9037
91. J.w. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab. 3 2006 177 185
92. M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIFalpha prolyl hydroxylase Cancer Cell 7 2005 77 85
93. J.S. Isaacs, Y.J. Jung, D.R. Mole, S. Lee, C. Torres-Cabala, Y.L. Chung, M. Merino, J. Trepel, B. Zbar, J. Toro, P.J. Ratcliffe, W.M. Linehan, and L. Neckers HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer. el role of fumarate in regulation of HIF stability Cancer Cell 8 2005 143 153
94. L.B. Sullivan, E. Martinez-Garcia, H. Nguyen, A.R. Mullen, E. Dufour, S. Sudarshan, J.D. Licht, R.J. DeBerardinis, and N.S. Chandel The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling Mol. Cell 51 2013 236 248
95. S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.L. Guan, and Y. Xiong Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 324 2009 261 265
96. S. Sudarshan, C. Sourbier, H.S. Kong, K. Block, V.A.V. Romero, Y. Yang, C. Galindo, M. Mollapour, B. Scroggins, N. Goode, M.J. Lee, C.W. Gourlay, J. Trepel, W.M. Linehan, and L. Neckers Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species Mol. Cell. Biol. 29 2009 4080 4090
97. W. Sun, S. Zhou, S.S. Chang, T. McFate, A. Verma, and J.A. Califano Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma Clin. Cancer Res. 15 2009 476 484
98. B. Brune, and J. Zhou Nitric oxide and superoxide: Interference with hypoxic signaling Cardiovasc. Res. 75 2007 275 282
99. M. Conacci-Sorrell, L. McFerrin, and R.N. Eisenman An overview of MYC and its interactome Cold Spring Harbor Perspect. Med 4 2014
100. C.J. David, M. Chen, M. Assanah, P. Canoll, and J.L. Manley HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Nature 463 2010 364 368
101. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, and C.B. Thompson Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. USA 105 2008 18782 18787
102. H. Zhang, P. Gao, R. Fukuda, G. Kumar, B. Krishnamachary, K.I. Zeller, C. Dang, and G.L. Semenza HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity Cancer Cell 11 2007 407 420
103. J. Kim, J.h. Lee, and V.R. Iyer Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-Box usage in vivo. PLoS One e1798 2008
104. F. Li, Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, K.A. O'Donnell, J.w. Kim, J.T. Yustein, L.A. Lee, and C.V. Dang Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis Mol. Cell. Biol. 25 2005 6225 6234
105. C. Berkers, O. Maddocks, E. Cheung, I. Mor, and K. Vousden Metabolic regulation by p53 family members (abstract) Cell Metab. 18 2013 617 633
106. F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression Cancer Res. 64 2004 2627 2633
107. H. Kondoh, M.E. Lleonart, J. Gil, J. Wang, P. Degan, G. Peters, D. Martinez, A. Carnero, and D. Beach Glycolytic enzymes can modulate cellular life span Cancer Res. 65 2005 177 185
108. K. Bensaad, A. Tsuruta, M.A. Selak, M.N.C. Vidal, K. Nakano, R. Bartrons, E. Gottlieb, and K.H. Vousden TIGAR, a p53-inducible regulator of glycolysis and apoptosis Cell 126 2006 107 120
109. H. Li, and G. Jogl Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator) J. Biol. Chem. 284 2009 1748 1754
110. S. Matoba, J.G. Kang, W.D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P.J. Hurley, F. Bunz, and P.M. Hwang p53 regulates mitochondrial respiration Science 312 2006 1650 1653
111. S. Suzuki, T. Tanaka, M.V. Poyurovsky, H. Nagano, T. Mayama, S. Ohkubo, M. Lokshin, H. Hosokawa, T. Nakayama, Y. Suzuki, S. Sugano, E. Sato, T. Nagao, K. Yokote, I. Tatsuno, and C. Prives Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species Proc. Natl. Acad. Sci. USA 107 2010 7461 7466
112. B.P. Tu, A. Kudlicki, M. Rowicka, and S.L. McKnight Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes Science 310 2005 1152 1158
113. N. Yahagi, H. Shimano, T. Matsuzaka, Y. Najima, M. Sekiya, Y. Nakagawa, T. Ide, S. Tomita, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, T. Gotoda, R. Nagai, S. Kimura, S. Ishibashi, J.i. Osuga, and N. Yamada p53 activation in adipocytes of obese mice J. Biol. Chem. 2003
114. R.A. Gatenby, and R.J. Gillies Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4 2004 891 899
115. 3 isomers J. Phys. Chem. 98 1994 10072 10078
116. B. Halliwell, and J.M. Gutteridge Free radicals in biology and medicine 1999 Oxford University Press Oxford
117. Y. Henry, M. Lepoivre, J.C. Drapier, C. Ducrocq, J.L. Boucher, and A. Guissani EPR characterization of molecular targets for NO in mammalian cells and organelles FASEB J. 7 1993 1124 1134
118. E. Antonini, and M. Brunori Hemoglobin and myoglobin in their reactions with ligands 1971 North Holland
119. A.J. Hobbs, and L.J. Ignarro Nitric oxide-cyclic GMP signal transduction system Methods Enzymol. 269 1996 134 148
120. S.P.L. Cary, J.A. Winger, and M.A. Marletta Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP Proc. Natl. Acad. Sci. USA 102 2005 13064 13069
121. M.W. Cleeter, J.M. Cooper, V.M. Darley-Usmar, S. Moncada, and A.H. Schapira Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases FEBS Lett. 345 1994 50 54
122. J.S. Beckman, and W.H. Koppenol Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly Am. J. Physiol. 271 1996 C1424 C1437
123. R. Radi Peroxynitrite a stealthy biological oxidant J. Biol. Chem 288 2013 26464 26472
124. F.J. Schopfer, P.R.S. Baker, G. Giles, P. Chumley, C. Batthyany, J. Crawford, R.P. Patel, N. Hogg, B.P. Branchaud, J.R. Lancaster Jr, and B.A. Freeman Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid is a hydrophobically-stabilized nitric oxide donor J. Biol. Chem 280 2005 19289 19297
125. D.A. Wink, J.S. Beckman, and P.C. Ford Kinetics of nitric oxide reaction in liquid and gas phase M. Feelisch, J.S. Stamler, Methods in nitric oxide research 1996 Wiley & Sons 29 37
126. S. Goldstein, and G. Czapski Kinetics of nitric oxide autoxidation in aqueous solution in the absence and presence of various reductants. The nature of the oxidizing intermediates J. Am. Chem. Soc. 117 1995 12078 12084
127. H.J. Forman, M. Torres, and J. Fukuto Redox signaling Mol. Cell. Biochem. 234-235 2002 49 62
128. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stamler Protein S-nitrosylation: purview and parameters Nat. Rev. Mol. Cell. Biol. 6 2005 150 166
129. K.A. Broniowska, and N. Hogg The chemical biology of S-nitrosothiols Antioxid. Redox Signal. 17 2012 969 980
130. P.T. Doulias, M. Tenopoulou, K. Raju, L.A. Spruce, S.H. Seeholzer, and H. Ischiropoulos Site specific identification of endogenous S-nitrosocysteine proteomes J. Proteomics 92 2013 195 203
131. S. Pervin, R. Singh, and G. Chaudhuri Nitric oxide, N[omega]-hydroxy-l-arginine and breast cancer Nitric Oxide 19 2008 103 106
132. L.A. Ridnour, D.D. Thomas, C. Switzer, W. Flores-Santana, J.S. Isenberg, S. Ambs, D.D. Roberts, and D.A. Wink Molecular mechanisms for discrete nitric oxide levels in cancer Nitric Oxide 19 2008 73 76
133. D.D. Thomas, L.A. Ridnour, J.S. Isenberg, W. Flores-Santana, C.H. Switzer, S. Donzelli, P. Hussain, C. Vecoli, N. Paolocci, S. Ambs, C.A. Colton, C.C. Harris, D.D. Roberts, and D.A. Wink The chemical biology of nitric oxide: implications in cellular signaling Free Radic. Biol. Med. 45 2008 18 31
134. L.A. Ridnour, D.D. Thomas, S. Donzelli, M.G. Espey, D.D. Roberts, D.A. Wink, and J.S. Isenberg The biphasic nature of nitric oxide responses in tumor biology Antioxid. Redox Signal. 8 2006 1329 1337
135. D.D. Roberts, J.S. Isenberg, L.A. Ridnour, and D.A. Wink Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis Clin. Cancer Res. 13 2007 795 798
136. D.D. Thomas, M.G. Espey, L.A. Ridnour, L.J. Hofseth, D. Mancardi, C.C. Harris, and D.A. Wink Hypoxic inducible factor 1a, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide Proc. Natl. Acad. Sci. USA 101 2004 8894 8899
137. S. Pervin, R. Singh, E. Hernandez, G. Wu, and G. Chaudhuri Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway Cancer Res. 67 2007 289 299
138. L.C. Jadeski, C. Chakraborty, and P.K. Lala Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase Int. J. Cancer 106 2003 496 504
139. A. Sanuphan, P. Chunhacha, V. Pongrakhananon, and P. Chanvorachote Long-term nitric oxide exposure enhances lung cancer cell migration BioMed. Res. Int 2013 2013
140. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
141. L.A. Ridnour, K.M. Barasch, A.N. Windhausen, T.H. Dorsey, M.M. Lizardo, H.G. Yfantis, D.H. Lee, C.H. Switzer, R.Y. Cheng, J.L. Heinecke, E. Brueggemann, H.B. Hines, C. Khanna, S.A. Glynn, S. Ambs, and D.A. Wink Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation PLoS. One 7 2012 e44081 2012
142. C. Switzer, R. Cheng, L. Ridnour, S. Glynn, S. Ambs, and D. Wink Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer Breast Cancer Res. 14 2012 R125
143. C.H. Switzer, S.A. Glynn, R.Y.S. Cheng, L.A. Ridnour, J.E. Green, S. Ambs, and D.A. Wink S-Nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer Mol. Cancer Res. 10 2012 1203 1215
144. B. Brune, K.A. von, and K.B. Sandau Nitric oxide and its role in apoptosis Eur. J. Pharmacol. 351 1998 261 272
145. L.A. Ridnour, D.D. Thomas, D. Mancardi, M.G. Espey, K.M. Miranda, N. Paolocci, M. Feelisch, J. Fukuto, and D.A. Wink The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations Biol. Chem. 385 2004 1 10
146. S. Pervin, R. Singh, W.A. Freije, and G. Chaudhuri MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer Cancer Res. 63 2003 8853 8860
147. D.J. Stuehr, and C.F. Nathan Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells J. Exp. Med. 169 1989 1543 1555
148. C.M. Snyder, E.H. Shroff, J. Liu, and N.S. Chandel Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members PLoS One 4 2009 e7059 2009
149. M. Lepoivre, J.M. Flaman, P. Bobe, G. Lemaire, and Y. Henry Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages J. Biol. Chem. 269 1994 21891 21897
150. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, and J.B. Mitchell The multifaced roles of nitric oxide in cancer Carcinogenesis 19 1998 711 721
151. D.D. Thomas, L.A. Ridnour, M.G. Espey, S. Donzelli, S. Ambs, S.P. Hussain, C.C. Harris, W. DeGraff, D.D. Roberts, J.B. Mitchell, and D.A. Wink Superoxide fluxes limit nitric oxide-induced signaling J. Biol. Chem. 281 2006 25984 25993
152. A. Acharya, I. Das, D. Chandhok, and T. Saha Redox regulation in cancer: a double-edged sword with therapeutic potential Oxid. Med. Cell Longev 3 2010 23 34
153. B. Brune The intimate relation between nitric oxide and superoxide in apoptosis and cell survival Antioxid. Redox Signal. 7 2005 497 507
154. B. Herr, J. Zhou, S. Drsoe, and B. Brnne The interaction of superoxide with nitric oxide destabilizes hypoxia-inducible factor-1a Cell. Mol. Life Sci. 64 2007 3295 3305
155. K.A. Broniowska, A.R. Diers, J.A. Corbett, and N. Hogg Nitric oxide effect on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and PARP activation Biochemistry 2013
156. J.P. Bolanos, and A. Almeida 5.2 Nitric oxide in regulation of mitochondrial function, respiration, and glycolysis A. Lajtha, G. Gibson, G. Dienel, Handbook of neurochemistry and molecular neurobiology 2007 Springer US 487 517
157. W.S. Jobgen, S.K. Fried, W.J. Fu, C.J. Meininger, and G. Wu Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates J. Nutr. Biochem. 17 2006 571 588
158. S. Moncada, and J.P. Bolanos Nitric oxide, cell bioenergetics and neurodegeneration J. Neurochem. 97 2006 1676 1689
159. G.C. Brown Nitric oxide and mitochondrial respiration Biochim. Biophys. Acta Bioenerg 1411 1999 351 369
160. G.C. Brown, and V. Borutaite Nitric oxide and mitochondrial respiration in the heart Cardiovasc. Res. 75 2007 283 290
161. V. Haynes, N.J. Traaseth, S. Elfering, Y. Fujisawa, and C. Giulivi Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging Am. J. Physiol. Endocrinol. Metab. 298 2010 E978 E987
162. K.S. Aulak, M. Miyagi, L. Yan, K.A. West, D. Massillon, J.W. Crabb, and D.J. Stuehr Proteomic method identifies proteins nitrated in vivo during inflammatory challenge Proc. Natl. Acad. Sci. USA 98 2001 12056 12061
163. C.L. Chen, J. Chen, S. Rawale, S. Varadharaj, P.P.T. Kaumaya, J.L. Zweier, and Y.R. Chen Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex ii in the post-ischemic myocardium J. Biol. Chem. 283 2008 27991 28003
164. A.A. Mongin, P. Dohare, and D. Jourd'heuil Selective vulnerability of synaptic signaling and metabolism to nitrosative stress Antioxid. Redox Signal. 17 2012 992 1012
165. B. Liu, A.K. Tewari, L. Zhang, K.B. Green-Church, J.L. Zweier, Y.R. Chen, and G. He Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target Biochim. Biophys. Acta Proteins Proteomics 1794 2009 476 485
166. G.C. Brown Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase FEBS Lett. 369 1995 136 139
167. A. Koivisto, A. Matthias, G. Bronnikov, and J. Nedergaard Kinetics of the inhibition of mitochondrial respiration by NO FEBS Lett. 417 1997 75 80
168. G.C. Brown, and C.E. Cooper Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase FEBS Lett. 356 1994 295 298
169. E. Clementi, G.C. Brown, N. Foxwell, and S. Moncada On the mechanism by which vascular endothelial cells regulate their oxygen consumption Proc. Natl. Acad. Sci. USA 96 1999 1559 1562
170. M. Schweizer, and C. Richter Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension Biochem. Biophys. Res. Commun. 204 1994 169 175
171. M.G. Mason, P. Nicholls, M.T. Wilson, and C.E. Cooper Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase Proc. Natl. Acad. Sci. USA 103 2006 708 713
172. M. Palacios-Callender, M. Quintero, V.S. Hollis, R.J. Springett, and S. Moncada Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase Proc. Natl. Acad. Sci. USA 101 2004 7630 7635
173. P.S. Brookes, D.W. Kraus, S. Shiva, J.E. Doeller, M.C. Barone, R.P. Patel, J.R. Lancaster Jr, and V. Darley-Usmar Control of mitochondrial respiration by NO. Effects of low oxygen and respiratory state J. Biol. Chem. 278 2003 31603 31609
174. C. Cooper Competitive, reversible, physiological? Inhibition of mitochondrial cytochrome oxidase by nitric oxide IUBMB Life 55 2003 591 597
175. J. Zhang, B. Jin, L. Li, E.R. Block, and J.M. Patel Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells Am. J. Physiol. Cell Physiol 288 2005 C840 C849
176. B.P. Dranka, B.G. Hill, and V.M. Darley-Usmar Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species Free Radic. Biol. Med. 48 2010 905 914
177. A. Ramachandran, E. Ceaser, and V.M. Darley-Usmar Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins Proc. Natl. Acad. Sci. USA 101 2004 384 389
178. L.S. Burwell, S.M. Nadtochiy, A.J. Tompkins, S. Young, and P.S. Brookes Direct evidence for S-nitrosation of mitochondrial complex I Biochem. J. 394 2006 627 634
179. E. Clementi, G.C. Brown, M. Feelisch, and S. Moncada Persistant inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione Proc. Natl. Acad. Sci. USA 95 1998 7631 7636
180. T. Yamamoto, W. Maruyama, Y. Kato, H. Yi, M. Shamoto-Nagai, M. Tanaka, Y. Sato, and M. Naoi Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells J. Neural Transm. 109 2002 1 13
181. N.A. Riobo, E. Clementi, M. Melani, A. Boveris, E. Cadenas, S. Moncada, and J.J. Poderoso Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation Biochem. J. 359 2001 139 145
182. M.T. Frost, Q. Wang, S. Moncada, and M. Singer Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages Am. J. Physiol. Regul. Integr. Comp. Physiol 288 2005 R394 R400
183. R. Welter, L. Yu, and C.A. Yu The effects of nitric oxide on electron transport complexes Arch. Biochem. Biophys. 331 1996 9 14
184. J.J. Poderoso, M.C. Carreras, C. Lisdero, N. Riobo, F. Schopfer, and A. Boveris Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles Arch. Biochem. Biophys. 328 1996 85 92
185. T.A. Prime, F.H. Blaikie, C. Evans, S.M. Nadtochiy, A.M. James, C.C. Dahm, D.A. Vitturi, R.P. Patel, C.R. Hiley, I. Abakumova, R. Requejo, E.T. Chouchani, T.R. Hurd, J.F. Garvey, C.T. Taylor, P.S. Brookes, R.A. Smith, and M.P. Murphy A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury Proc. Natl. Acad. Sci. USA 106 2009 10764 10769
186. S. Shiva, M.N. Sack, J.J. Greer, M. Duranski, L.A. Ringwood, L. Burwell, X. Wang, P.H. Macarthur, A. Shoja, N. Raghavachari, J.W. Calvert, P.S. Brookes, D.J. Lefer, and M.T. Gladwin Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer J. Exp. Med. 2007
187. E.M. Richards, R.E. Rosenthal, T. Kristian, and G. Fiskum Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity Free Radic. Biol. Med. 40 2006 1960 1970
188. J.C. Drapier, and J.B. Hibbs Jr. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible J. Clin. Invest. 78 1986 790 797
189. L. Castro, M. Rodriguez, and R. Radi Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide J. Biol. Chem. 269 1994 29409 29415
190. V. Tortora, C. Quijano, B. Freeman, R. Radi, and L. Castro Mitochondrial aconitase reaction with nitric oxide, S-nitrosoglutathione, and peroxynitrite: mechanisms and relative contributions to aconitase inactivation Free Radic. Biol. Med. 42 2007 1075 1088
191. D. Han, R. Canali, J. Garcia, R. Aguilera, T.K. Gallaher, and E. Cadenas Sites and mechanisms of aconitase inactivation by peroxynitrite: modulation by citrate and glutathione Biochemistry 44 2005 11986 11996
192. L. Castro, V. Demicheli, V. Tortora, and R. Radi Mitochondrial protein tyrosine nitration Free Radic. Res. 45 2010 37 52
193. E.T. Chouchani, T.R. Hurd, S.M. Nadtochiy, P.S. Brookes, I.M. Fearnley, K.S. Lilley, R.A. Smith, and M.P. Murphy Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation Biochem. J. 430 2010 49 59
194. E.S. Yang, C. Richter, J.S. Chun, T.L. Huh, S.S. Kang, and J.W. Park Inactivation of NADP+-dependent isocitrate dehydrogenase by nitric oxide Free Radic. Biol. Med. 33 2002 927 937
195. Q. Shi, H. Xu, H. Yu, N. Zhang, Y. Ye, A.G. Estevez, H. Deng, and G.E. Gibson Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex J. Biol. Chem. 286 2011 17640 17648
196. C.A. Piantadosi, and H.B. Suliman Redox regulation of mitochondrial biogenesis Free Radic. Biol. Med. 53 2012 2043 2053
197. E. Bossy-Wetzel, and S.A. Lipton Nitric oxide signaling regulates mitochondrial number and function Cell Death Differ. 10 2003 757 760
198. E. Nisoli, C. Tonello, A. Cardile, V. Cozzi, R. Bracale, L. Tedesco, S. Falcone, A. Valerio, O. Cantoni, E. Clementi, S. Moncada, and M.O. Carruba Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS Science 310 2005 314 317
199. E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, R. Bracale, A. Valerio, M. Francolini, S. Moncada, and M.O. Carruba Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 299 2003 896 899
200. E. Clementi, and E. Nisoli Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism Comp. Biochem. Physiol. A Mol. Integr. Physiol 142 2005 102 110
201. V.A. Lira, D.L. Brown, A.K. Lira, A.N. Kavazis, Q.A. Soltow, E.H. Zeanah, and D.S. Criswell Nitric oxide and AMPK cooperatively regulate PGC-1a in skeletal muscle cells J. Physiol. 588 2010 3551 3566
202. G.K. McConell, G.P.Y. Ng, M. Phillips, Z. Ruan, S.L. Macaulay, and G.D. Wadley Central role of nitric oxide synthase in AICAR and caffeine-induced mitochondrial biogenesis in L6 myocytes J. Appl. Physiol. 108 2010 589 595
203. S. Jager, C. Handschin, J. Pierre, and B.M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc. Natl. Acad. Sci. USA 104 2007 12017 12022
204. S.L. Colombo, and S. Moncada AMPKalpha1 regulates the antioxidant status of vascular endothelial cells Biochem. J. 421 2009 163 169
205. M. Quintero, P.A. Brennan, G.J. Thomas, and S. Moncada Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation Cancer Res. 66 2006 770 774
206. M.H. Zou, S.S. Kirkpatrick, B.J. Davis, J.S. Nelson, W.G. Wiles, U. Schlattner, D. Neumann, M. Brownlee, M.B. Freeman, and M.H. Goldman Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo: role of mitochondrial reactive nitrogen species J. Biol. Chem. 279 2004 43940 43951
207. M.H. Zou, X.Y. Hou, C.M. Shi, S. Kirkpatick, F. Liu, M.H. Goldman, and R.A. Cohen Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells: role of peroxynitrite J. Biol. Chem. 278 2003 34003 34010
208. P. Cidad, A. Almeida, and J.P. Bolanos Inhibition of mitochondrial respiration by nitric oxide rapidly stimulates cytoprotective GLUT3-mediated glucose uptake through 5′-AMP-activated protein kinase Biochem. J. 384 2004 629 636
209. A. Almeida, S. Moncada, and J.P. Bolanos Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway Nat. Cell Biol. 6 2004 45 51
210. L. Bergandi, F. Silvagno, I. Russo, C. Riganti, G. Anfossi, E. Aldieri, D. Ghigo, M. Trovati, and A. Bosia Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 23 2003 2215 2221
211. G.K. McConell, and G.D. Wadley Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle Clin. Exp. Pharmacol. Physiol. 35 2008 1488 1492
212. T. Hagen, C.T. Taylor, F. Lam, and S. Moncada Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha Science 302 2003 1975 1978
213. K.B. Sandau, J. Fandrey, and B. Brune Accumulation of HIF-1alpha under the influence of nitric oxide Blood 97 2001 1009 1015
214. R. Chowdhury, L.C. Godoy, A. Thiantanawat, L.J. Trudel, W.M. Deen, and G.N. Wogan Nitric oxide produced endogenously is responsible for hypoxia-induced HIF-1alpha stabilization in colon carcinoma cells Chem. Res. Toxicol. 25 2012 2194 2202
215. F. Li, P. Sonveaux, Z.N. Rabbani, S. Liu, B. Yan, Q. Huang, Z. Vujaskovic, M. Dewhirst, and C.Y. Li Regulation of HIF-1alpha stability through S-nitrosylation Mol. Cell 26 2007 63 74
216. B. Brix, J.R. Mesters, L. Pellerin, and O. Johren Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1alpha-mediated target gene activation J. Neurosci. 32 2012 9727 9735
217. S. Mohr, H. Hallak, A. de Boitte, E.G. Lapetina, and B. Brüne Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase J. Biol. Chem. 274 1999 9427 9430
218. K.A. Broniowska, and N. Hogg Differential mechanisms of inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by S-nitrosothiols and NO in cellular and cell-free conditions Am. J. Physiol. Heart Circ. Physiol 299 2010 H1212 H1219
219. D.P. Buchczyk, T. Grune, H. Sies, and L.O. Klotz Modifications of glyceraldehyde-3-phosphate dehydrogenase induced by increasing concentrations of peroxynitrite: early recognition by 20S proteasome Biol. Chem. 384 2003 237 241
220. J.M. Souza, and R. Radi Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite Arch. Biochem. Biophys. 360 1998 187 194
221. Y. Sekar, T.C. Moon, C.M. Slupsky, and A.D. Befus Protein tyrosine nitration of aldolase in mast cells: a plausible pathway in nitric oxide-mediated regulation of mast cell function J. Immunol. 185 2010 578 587
222. T. Koeck, B. Levison, S.L. Hazen, J.W. Crabb, D.J. Stuehr, and K.S. Aulak Tyrosine nitration impairs mammalian aldolase A activity Mol. Cell. Proteomics 3 2004 548 557
223. M. Vakkala, K. Kahlos, E. Lakari, P. Paakko, V. Kinnula, and Y. Soini Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas Clin. Cancer Res. 6 2000 2408 2416
224. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, and S. Moncada Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. USA 92 1995 4392 4396
225. S. Loibl, A. Buck, C. Strank, G. von Minckwitz, M. Roller, H.P. Sinn, V. Schini-Kerth, C. Solbach, K. Strebhardt, and M. Kaufmann The role of early expression of inducible nitric oxide synthase in human breast cancer Eur. J. Cancer 41 2005 265 271
226. A. Bulut, E. Erden, S. Sak, H. Doruk, N. Kursun, and D. Dincol Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases Virchows Arch. 447 2005 24 30
227. L.L. Thomsen, D.W. Miles, L. Happerfield, L.G. Bobrow, R.G.; RG Knowles, and S. Moncada Nitric oxide synthase activity in human breast cancer Br. J. Cancer 72 1995 41 44
228. S.A. Glynn, B.J. Boersma, T.H. Dorsey, M. Yi, H.G. Yfantis, L.A. Ridnour, D.N. Martin, C.H. Switzer, R.S. Hudson, D.A. Wink, D.H. Lee, R.M. Stephens, and S. Ambs Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients J. Clin. Invest. 120 2010 3843 3854
229. C.H. Switzer, S.A. Glynn, L.A. Ridnour, R.Y.S. Cheng, M.P. Vitek, S. Ambs, and D.A. Wink Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer Trends Pharmacol. Sci. 32 2011 644 651
230. R.A. Gatenby, K. Smallbone, P.K. Maini, F. Rose, J. Averill, R.B. Nagle, L. Worrall, and R.J. Gillies Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer Br. J. Cancer 97 2007 646 653
231. A. Isidoro, E. Casado, A. Redondo, P. Acebo, E. Espinosa, A.M. Alonso, P. Cejas, D. Hardisson, J.A. Fresno Vara, C. Belda-Iniesta, M. Gonzaílez-Baron, and J.M. Cuezva Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis Carcinogenesis 26 2005 2095 2104
232. L. Jerby, L. Wolf, C. Denkert, G.Y. Stein, M. Hilvo, M. Oresic, T. Geiger, and E. Ruppin Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer Cancer Res. 72 2012 5712 5720
233. M.L. McCleland, A.S. Adler, Y. Shang, T. Hunsaker, T. Truong, D. Peterson, E. Torres, L. Li, B. Haley, J.P. Stephan, M. Belvin, G. Hatzivassiliou, E.M. Blackwood, L. Corson, M. Evangelista, J. Zha, and R. Firestein An integrated genomic screen identifies ldhb as an essential gene for triple-negative breast cancer Cancer Res. 72 2012 5812 5823
234. C.A. Caneba, L. Yang, J. Baddour, R. Curtis, J. Win, S. Hartig, J. Marini, and D. Nagrath Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells Cell Death. Dis 5 2014 e1302 2014